
Zenas BioPharma, Inc.
USD17.40
+0.27 (+1.58%)
CEO
Leon Oliver Moulder Jr.
IPO Date
2024-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.16
Prev. Close
$17.13
Day Low
$17.05
Day High
$17.78
52W Low
$8.91
52W High
$44.60
Market Cap
$0.78B
Volume
0.41M
| 17 Mar 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 17 Mar 2026 | Guggenheim | Buy | Buy | maintain |
| 17 Mar 2026 | Citigroup | Buy | Buy | maintain |
| 10 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 6 Jan 2026 | Morgan Stanley | Overweight | Equal Weight | downgrade |
| 22 Dec 2025 | Wedbush | Outperform | Outperform | maintain |
| 13 Nov 2025 | Morgan Stanley | Overweight | Overweight | maintain |